Compare ECOR & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | ALIS |
|---|---|---|
| Founded | 2005 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 85.9M |
| IPO Year | 2018 | 2024 |
| Metric | ECOR | ALIS |
|---|---|---|
| Price | $11.33 | $10.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 80.6K | 45.9K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | $258.50 |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.41 | $9.87 |
| 52 Week High | $12.70 | $10.40 |
| Indicator | ECOR | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 67.28 |
| Support Level | $5.70 | $10.05 |
| Resistance Level | N/A | $10.40 |
| Average True Range (ATR) | 0.69 | 0.03 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 64.23 | 50.00 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.